NextCure, Inc. (NXTC)
NASDAQ · Healthcare
NextCure, Inc. EPS 2020–2025
NextCure, Inc. annual/quarterly eps history and growth rate from 2020 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- NextCure, Inc. eps for the quarter ending March 31, 2026 was $1.87, a 60.04% decrease year-over-year.
- NextCure, Inc. annual eps for 2025 was $19.65, a 17.71% decrease from 2024.
- NextCure, Inc. annual eps for 2024 was $23.88, a 961.33% increase from 2023.
- NextCure, Inc. annual eps for 2023 was $2.25, a 16.36% decrease from 2022.
- NextCure, Inc. annual eps for 2022 was $2.69.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
NextCure, Inc. EPS — FAQ
NextCure, Inc. (NXTC) eps over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is NextCure, Inc.'s eps?
NextCure, Inc. (NXTC) reported eps of $-19.65 for fiscal 2025.
Where can I see NXTC's eps history?
The chart and table above show NextCure, Inc.'s eps by year and by quarter, including the growth rate.